KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oscar Health (OSCR) Enterprise Value (2021 - 2026)

Oscar Health's Enterprise Value history spans 6 years, with the latest figure at -$4.0 billion for Q4 2025.

  • For Q4 2025, Enterprise Value fell 85.57% year-over-year to -$4.0 billion; the TTM value through Dec 2025 reached -$4.0 billion, down 85.57%, while the annual FY2025 figure was -$4.0 billion, 85.57% down from the prior year.
  • Enterprise Value reached -$4.0 billion in Q4 2025 per OSCR's latest filing, down from -$3.0 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1.7 billion in Q3 2021 to a low of -$4.0 billion in Q4 2025.
  • Average Enterprise Value over 5 years is -$2.8 billion, with a median of -$2.8 billion recorded in 2022.
  • Peak YoY movement for Enterprise Value: plummeted 451.2% in 2021, then soared 30.09% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$1.7 billion in 2021, then plummeted by 75.22% to -$3.0 billion in 2022, then grew by 13.4% to -$2.6 billion in 2023, then increased by 16.0% to -$2.1 billion in 2024, then crashed by 85.57% to -$4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Enterprise Value are -$4.0 billion (Q4 2025), -$3.0 billion (Q3 2025), and -$3.5 billion (Q2 2025).